$72.33+0.42 (+0.58%)
Ollie's Bargain Outlet Holdings, Inc.
Ollie's Bargain Outlet Holdings, Inc. in the Consumer Defensive sector is trading at $72.33 with a market capitalization of $5.0B. Wall Street consensus targets $120.20 (15 analysts), implying a +66.2% move over the next 12 months. The stock is currently near its 52-week low of $70.85, remaining 32.0% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $779.26M↑ | $613.62M↓ | $679.56M↑ | $576.77M↓ | $667.08M |
| Gross Profit | $310.92M↑ | $253.65M↓ | $271.34M↑ | $237.03M↓ | $271.60M |
| Operating Income | $111.34M↑ | $62.81M↓ | $85.95M↑ | $62.84M↓ | $92.55M |
| Net Income | $85.55M↑ | $46.17M↓ | $61.31M↑ | $47.56M↓ | $68.55M |
Ollie's Bargain Outlet Holdings, Inc. operates as a retailer of closeout merchandise and excess inventory in the United States. The company offers health and beauty aids, food, candy, beverages, pet food and treats, laundry related products, and clea...
Curious whether Ollie's Bargain Outlet Holdings is trading at a bargain or already pricing in high expectations? This article walks through what the current share price might be implying about the stock. The share price closed at US$74.09, with the stock down 3.7% over the past week, 8.1% over the past month, 33.4% year to date, and 44.5% over the past year. The 3 year return sits at 28.3%, while the 5 year return is down 13.3%. Recent coverage around Ollie's Bargain Outlet Holdings has...
Ollie's Bargain Outlet (OLLI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Inflation resistant stocks provide consitent cash flow and capital returns, helping to reduce portfolio volatility and enhance total returns over time.
With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.